Select Bio Conference

The SARS-CoV-2 Coronavirus Pandemic is evolving and the various variants which currently are driving the pandemic forward are responsible for morbidity, mortality and economic strains globally. This virtual 2-day conference takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing and expectations for the future role of Microfluidics in the Management of Pandemics. The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field - Providing them a platform to present their technology/offering to the community and engage. In addition to presentations, there will be virtual posters to highlight technologies and late-breaking developments. This virtual conference is powered by Zoom and chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.

Agenda Topics

• Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
• Lateral Flow Assays
• Microfluidics Impact on SARS-CoV-2 Testing: Current Status and Future
• Technical Solutions for Rapid COVID-19 Testing
• Nucleic Acid Diagnostic Tests and Rapid Testing: Evolution of the Space
• Organoids and Organs-on-Chips to Model SARS-CoV-2 Infection Ex Vivo
• Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance
• SARS-CoV-2 Rapid Diagnostics and Global Health
• Vaccine Development